{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:31:00Z","timestamp":1794436260292,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Institute for Translational Sciences at the University of Texas Medical Branch and Clinical and Translational Science Award NRSA (TL1) Training Core","award":["TL1TR001440"],"award-info":[{"award-number":["TL1TR001440"]}]},{"name":"The University of Texas Medical Branch at Galveston startup funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Migraine ranks among the most prevalent disorders worldwide, leading to disability and decreased quality of life in patients. Recently, neurogenic inflammation has been recognized as a potential underlying pathology contributing to the migraine pain pathway. Mast cells reside in the meninges and have been implicated in contributing to the pathophysiology of migraine. Here we report for the first time that the mouse Mas-Related G-protein-coupled Receptor B2 (MrgprB2), is expressed on meningeal connective tissue mast cells and contributes to Pituitary Adenylate Cyclase Activating Peptide (PACAP)-induced migraine-like pain behavior. We also found that PACAP was able to dose-dependently lead to enzyme release from human mast cells via activation of MRGPRX2; the human homolog of MrgprB2. Using a transgenic MRGPRX2 mouse, we observed significant increases in PACAP-induced migraine-like pain behavior in MRGPRX2\n                    <jats:sup>+<\/jats:sup>\n                    mice vs mice lacking the receptor. These results reveal both MrgprB2 and MRGPRX2 as important contributors to neuropeptide-induced migraine pain.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-39571-y","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T06:02:04Z","timestamp":1690610524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain"],"prefix":"10.1038","volume":"13","author":[{"given":"Sami","family":"Sbei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Moncrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathachit","family":"Limjunyawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin P.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"issue":"1","key":"39571_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biomedicines10010076","volume":"10","author":"E Spekker","year":"2021","unstructured":"Spekker, E. et al. Neurogenic inflammation: The participant in migraine and recent advancements in translational research. Biomedicines 10(1), 7 (2021).","journal-title":"Biomedicines"},{"issue":"8","key":"39571_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","volume":"15","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson, L., Haanes, K. A. & Warfvinge, K. Does inflammation have a role in migraine?. Nat. Rev. Neurol. 15(8), 483\u2013490 (2019).","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"39571_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.neuron.2019.01.012","volume":"101","author":"DP Green","year":"2019","unstructured":"Green, D. P. et al. A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron 101(3), 412-420e3 (2019).","journal-title":"Neuron"},{"issue":"1","key":"39571_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chom.2019.06.003","volume":"26","author":"P Pundir","year":"2019","unstructured":"Pundir, P. et al. A connective tissue mast-cell-specific receptor detects bacterial quorum-sensing molecules and mediates antibacterial immunity. Cell Host Microbe 26(1), 114-122e8 (2019).","journal-title":"Cell Host Microbe"},{"key":"39571_CR5","doi-asserted-by":"publisher","first-page":"174480691986784","DOI":"10.1177\/1744806919867842","volume":"15","author":"R Ramachandran","year":"2019","unstructured":"Ramachandran, R. et al. Role of Toll-like receptor 4 signaling in mast cell-mediated migraine pain pathway. Mol. Pain 15, 1744806919867842 (2019).","journal-title":"Mol. Pain"},{"issue":"2","key":"39571_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","volume":"46","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli, P. et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46(2), 200\u2013207 (2006).","journal-title":"Headache"},{"issue":"2","key":"39571_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbi.2011.09.016","volume":"26","author":"D Levy","year":"2012","unstructured":"Levy, D. et al. Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity. Brain Behav. Immun. 26(2), 311\u2013317 (2012).","journal-title":"Brain Behav. Immun."},{"issue":"1\u20132","key":"39571_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","volume":"130","author":"D Levy","year":"2007","unstructured":"Levy, D. et al. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130(1\u20132), 166\u2013176 (2007).","journal-title":"Pain"},{"issue":"15","key":"39571_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1177\/0333102411421683","volume":"31","author":"JH Smith","year":"2011","unstructured":"Smith, J. H., Butterfield, J. H. & Cutrer, F. M. Primary headache syndromes in systemic mastocytosis. Cephalalgia 31(15), 1522\u20131531 (2011).","journal-title":"Cephalalgia"},{"issue":"13","key":"39571_CR10","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka, B. et al. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia 33(13), 1085\u20131095 (2013).","journal-title":"Cephalalgia"},{"issue":"Pt 1","key":"39571_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz, H. W. et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(Pt 1), 16\u201325 (2009).","journal-title":"Brain"},{"issue":"1","key":"39571_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0333102420970889","volume":"41","author":"M Ashina","year":"2021","unstructured":"Ashina, M. et al. A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41(1), 33\u201344 (2021).","journal-title":"Cephalalgia"},{"issue":"1","key":"39571_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-023-01599-w","volume":"24","author":"NB Rasmussen","year":"2023","unstructured":"Rasmussen, N. B. et al. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: An interventional, randomized, double-blind, parallel-group, placebo-controlled study. J. Headache Pain 24(1), 60 (2023).","journal-title":"J. Headache Pain"},{"issue":"7","key":"39571_CR14","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/brain\/awac040","volume":"145","author":"C Ernstsen","year":"2022","unstructured":"Ernstsen, C. et al. The PACAP pathway is independent of CGRP in mouse models of migraine: Possible new drug target?. Brain 145(7), 2450\u20132460 (2022).","journal-title":"Brain"},{"issue":"21","key":"39571_CR15","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1523\/JNEUROSCI.2200-20.2021","volume":"41","author":"A Kuburas","year":"2021","unstructured":"Kuburas, A. et al. PACAP induces light aversion in mice by an inheritable mechanism independent of CGRP. J. Neurosci. 41(21), 4697\u20134715 (2021).","journal-title":"J. Neurosci."},{"issue":"7542","key":"39571_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"BD McNeil","year":"2015","unstructured":"McNeil, B. D. et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519(7542), 237\u2013241 (2015).","journal-title":"Nature"},{"key":"39571_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2019.00114","volume":"13","author":"SH Pedersen","year":"2019","unstructured":"Pedersen, S. H. et al. PACAP-38 and PACAP(6\u201338) degranulate rat meningeal mast cells via the orphan MrgB3-receptor. Front. Cell Neurosci. 13, 114 (2019).","journal-title":"Front. Cell Neurosci."},{"issue":"5","key":"39571_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","volume":"50","author":"J Meixiong","year":"2019","unstructured":"Meixiong, J. et al. Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch. Immunity 50(5), 1163\u201311715 (2019).","journal-title":"Immunity"},{"issue":"1","key":"39571_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0333102418779557","volume":"39","author":"CC Burgos-Vega","year":"2019","unstructured":"Burgos-Vega, C. C. et al. Non-invasive dural stimulation in mice: A novel preclinical model of migraine. Cephalalgia 39(1), 123\u2013134 (2019).","journal-title":"Cephalalgia"},{"issue":"4","key":"39571_CR20","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbrc.2006.08.177","volume":"349","author":"K Tatemoto","year":"2006","unstructured":"Tatemoto, K. et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem. Biophys. Res Commun. 349(4), 1322\u20131328 (2006).","journal-title":"Biochem. Biophys. Res Commun."},{"issue":"1","key":"39571_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0333102418779548","volume":"39","author":"SN Hassler","year":"2019","unstructured":"Hassler, S. N. et al. Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice. Cephalalgia 39(1), 111\u2013122 (2019).","journal-title":"Cephalalgia"},{"issue":"4","key":"39571_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun, M. et al. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32(4), 337\u2013345 (2012).","journal-title":"Cephalalgia"},{"key":"39571_CR23","doi-asserted-by":"publisher","first-page":"174480692311813","DOI":"10.1177\/17448069231181358","volume":"19","author":"LC Guan","year":"2023","unstructured":"Guan, L. C., Dong, X. & Green, D. P. Roles of mast cells and their interactions with the trigeminal nerve in migraine headache. Mol. Pain 19, 17448069231181358 (2023).","journal-title":"Mol. Pain"},{"issue":"1","key":"39571_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar, A. J. et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br. J. Pharmacol. 166(1), 4\u201317 (2012).","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"39571_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.50","volume":"121","author":"A Louveau","year":"2018","unstructured":"Louveau, A., Filiano, A. J. & Kipnis, J. Meningeal whole mount preparation and characterization of neural cells by flow cytometry. Curr. Protoc. Immunol. 121(1), e50 (2018).","journal-title":"Curr. Protoc. Immunol."}],"updated-by":[{"DOI":"10.1038\/s41598-023-40309-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39571-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39571-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39571-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:09:12Z","timestamp":1700460552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39571-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39571"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39571-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"assertion":[{"value":"7 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-40309-z","URL":"https:\/\/doi.org\/10.1038\/s41598-023-40309-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12302"}}